Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $7.4050 (2.85%) ($7.4050 - $7.4050) on Thu. Jul. 13, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.91% (three month average) | RSI | 65 | Latest Price | $7.4050(2.85%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 1.1% a day on average for past five trading days. | Weekly Trend | BCRX advances 1.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(36%) VCIT(26%) BND(25%) SHY(25%) IBB(24%) | Factors Impacting BCRX price | BCRX will decline at least -1.455% in a week (0% probabilities). XLRE(-30%) XLP(-25%) SPLV(-20%) TBT(-19%) DIA(-19%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -1.455% (StdDev 2.91%) | Hourly BBV | 0.1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $7.22(2.56%) | 10 Day Moving Average | $7.13(3.86%) | 20 Day Moving Average | $7.2(2.85%) | To recent high | -16.4% | To recent low | 6.7% | Market Cap | $1.306b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |